Clinical Diagnostics News and Research

RSS

STRATEC Molecular offers new products to improve liquid biopsy

Liquid biopsy is a new technology for detection and analysis of biomarkers in blood or other body fluids without the need of invasive procedures.

28 Jul 2017

Bio-Rad receives FDA clearance for IH-1000 blood typing instrument for the U.S. market

Bio-Rad Laboratories, Inc., a global provider of life science research and clinical diagnostic products, today announced that it has received clearance from the U.S. Food and Drug Administration for its IH-1000 blood typing instrument along with approvals for a wide range of associated gel cards and reagents for the U.S. blood typing market.

25 Jul 2017

Diagnosing prostate cancer through a £225 urine test

This test, which we have branded SelectMDx for Prostate Cancer, came with the acquisition of a company in the Netherlands called NovioGendix. They developed a prototype assay, so they did most of the heavy lifting in terms of discovering the two specific biomarkers that are currently in the product. These biomarkers are tuned towards the detection of what I call clinically significant prostate cancer.

24 Jul 2017

New OpenArray system offers simultaneous detection of pathogens in blood samples

The emergence of new pathogens like West Nile Virus, Ebola, Dengue, and Zika, threaten human health on a global scale.

From Thermo Fisher Scientific - Microbiology 13 Jun 2017

Rainin provides excellent pipette service to regulated pharmaceutical and clinical diagnostics industries

Careful maintenance of precision pipettes is essential in the highly regulated pharmaceutical and clinical diagnostics industries.

From Mettler-Toledo International Inc. 31 Mar 2017

Microsystems engineer wins award for dissertation on optimization of biosensors for diagnosing diseases

The microsystems engineer Dr. Can Dincer from University of Freiburg has been awarded by the second place in Gips-Schüle Young Scientist Award for his dissertation on the optimization of biosensor systems for diagnosing diseases.

31 Jan 2017

NMR and metabolic phenotyping

In this interview, Dr Harmut Schafer introduces the work being done at the Phenome Center in Birmingham, on metabolic phenotyping using NMR.

From Bruker BioSpin - NMR, EPR and Imaging 31 Jan 2017

Tecan ensures ease of pipetting with Liquid Handling Arm™ disposable tip

Tecan is simplifying handling of biological fluids with the introduction of a wide bore version of its popular 1,000 μl Liquid Handling Arm™ (LiHa) disposable tip.

From Tecan 11 Jan 2017

FDA approves new fully automated blood analyzer for high-volume transfusion labs

Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, today announced that ORTHO VISION Max, a fully automated blood analyzer for high-volume transfusion medicine laboratories, received 510(k) clearance, signifying its conformity with U.S. Food and Drug Administration regulation.

24 Oct 2016

PCL Alverno to highlight successful partnership with Beckman Coulter Diagnostics at Lab Quality Confab 2016

PCL Alverno (Hammond, Ind.), recipient of the prestigious ADVANCE Laboratory of the Year award for 2016, will share its strategies for implementing a culture of continuous improvement and lab efficiency at the 10th Anniversary Lab Quality Confab, held October 18-19, 2016, in New Orleans.

From Beckman Coulter Diagnostics 14 Oct 2016

TUM scientists develop bioinformatics tool that allows worldwide bacterial analysis

Sequencing data from biological samples such as the skin, intestinal tissues, or soil and water are usually archived in public databases.

6 Oct 2016

EVG brings high-volume manufacturing process solutions to biotechnology and medical device market

EV Group, a leading supplier of wafer bonding and lithography equipment for the MEMS, nanotechnology and semiconductor markets, today announced that it is increasing its focus on bringing its high-volume manufacturing process solutions and services to the biotechnology and medical device market.

27 Sep 2016

Food intolerance testing: an interview with Dr Gill Hart

Food intolerances are caused by adverse reactions to food or drink ingredients in your body. These are very different to food allergies. It is estimated that up to forty-five percent of the population suffers from food intolerances.

15 Sep 2016

Is the virtual gene panel the way forward asks Congenica at Dx Summit

Although the current practice of analysing defined gene panels for a specific disease has great utility, it is of limited benefit when a condition is not well defined.

29 Aug 2016

New bioinspired device could diagnose formation of blood clots

When in dysfunction, the vascular endothelium -- the tissue that lines the blood vessels throughout our body's entire circulatory system -- plays a big role in the development of many human diseases, including diabetes, stroke, heart disease, viral infections and cancer.

9 Aug 2016

Ortho Clinical Diagnostics to showcase seven posters of vital tests, six products at AACC meeting

Ortho Clinical Diagnostics today announced it will present seven scientific posters on its assays and display six products at its booth at the 2016 American Association for Clinical Chemistry annual meeting.

30 Jul 2016

Aelan's researchers develop novel epigenetic biomarker for diagnosis of AD

Aelan Cell Technologies today announced the development of a novel epigenetic biomarker. An early human clinical feasibility study has indicated that serological tests using the biomarker alongside other proprietary components developed by Aelan's researchers could potentially help physicians diagnose Alzheimer's disease (AD).

12 Jul 2016

Scientists detect gene networks likely to be shared by all CLL patients

Research, involving scientists and doctors at the University of Southampton and Royal Bournemouth Hospital, has identified a network of genes that are likely to be shared by all patients who have chronic lymphocytic leukaemia (CLL).

28 Jun 2016

Tackling healthcare challenges in a changing world: an interview with Professor Jeremy Nicholson

As individuals and as populations our risks of getting diseases are determined partly genetically and partly from the environment that we live in. An important part of that environment that mediates between the outside world and the inside world of our bodies is the microbiome.

10 Jun 2016

New microfluidic device helps extract rare target cells from background cells

A team of researchers from University of Cincinnati in Cincinnati, OH have developed a novel microfluidic device, which combines the inertial effect of fluid and microscale vortices generated in microchambers, to achieve simultaneous double sorting of rare target cells and removal of background cells.

23 May 2016